perbb3 Search Results


90
R&D Systems human perbb3 elisa kit
Human Perbb3 Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human perbb3 elisa kit/product/R&D Systems
Average 90 stars, based on 1 article reviews
human perbb3 elisa kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc anti perbb3
Anti Perbb3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti perbb3/product/Cell Signaling Technology Inc
Average 94 stars, based on 1 article reviews
anti perbb3 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

90
Cell Signaling Technology Inc perbb3-y1289 antibody
Perbb3 Y1289 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/perbb3-y1289 antibody/product/Cell Signaling Technology Inc
Average 90 stars, based on 1 article reviews
perbb3-y1289 antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Santa Cruz Biotechnology primary monoclonal antibodies for perbb3
IHC analysis of xenograft tumours with and without CAF and effect of erlotinib treatment. The photographs ( A , B ) show low power (4 × ) representative sections of α -SMA staining of AsPC-1 and AsPC-1+CAF xenografts, respectively. The photographs ( C , D ) show representative sections of <t>pErbB3</t> expression in erlotinib-treated AsPC-1 and AsPC-1+CAF xenografts. A high power (20 × ) view demonstrates positive membranous pattern, scored as intensity 2 on a 0–3 scale ( D ), the opposite ( C ) shows negative staining. The photographs ( E , F ) show representative sections of pErbB3 staining in placebo-treated AsPC-1 and AsPC-1+CAF xenografts.
Primary Monoclonal Antibodies For Perbb3, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary monoclonal antibodies for perbb3/product/Santa Cruz Biotechnology
Average 90 stars, based on 1 article reviews
primary monoclonal antibodies for perbb3 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

97
Abcam perbb3
IHC analysis of xenograft tumours with and without CAF and effect of erlotinib treatment. The photographs ( A , B ) show low power (4 × ) representative sections of α -SMA staining of AsPC-1 and AsPC-1+CAF xenografts, respectively. The photographs ( C , D ) show representative sections of <t>pErbB3</t> expression in erlotinib-treated AsPC-1 and AsPC-1+CAF xenografts. A high power (20 × ) view demonstrates positive membranous pattern, scored as intensity 2 on a 0–3 scale ( D ), the opposite ( C ) shows negative staining. The photographs ( E , F ) show representative sections of pErbB3 staining in placebo-treated AsPC-1 and AsPC-1+CAF xenografts.
Perbb3, supplied by Abcam, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/perbb3/product/Abcam
Average 97 stars, based on 1 article reviews
perbb3 - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier

90
Cell Signaling Technology Inc p110α-4249 antibody
IHC analysis of xenograft tumours with and without CAF and effect of erlotinib treatment. The photographs ( A , B ) show low power (4 × ) representative sections of α -SMA staining of AsPC-1 and AsPC-1+CAF xenografts, respectively. The photographs ( C , D ) show representative sections of <t>pErbB3</t> expression in erlotinib-treated AsPC-1 and AsPC-1+CAF xenografts. A high power (20 × ) view demonstrates positive membranous pattern, scored as intensity 2 on a 0–3 scale ( D ), the opposite ( C ) shows negative staining. The photographs ( E , F ) show representative sections of pErbB3 staining in placebo-treated AsPC-1 and AsPC-1+CAF xenografts.
P110α 4249 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p110α-4249 antibody/product/Cell Signaling Technology Inc
Average 90 stars, based on 1 article reviews
p110α-4249 antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc perbb3 y1197
IHC analysis of xenograft tumours with and without CAF and effect of erlotinib treatment. The photographs ( A , B ) show low power (4 × ) representative sections of α -SMA staining of AsPC-1 and AsPC-1+CAF xenografts, respectively. The photographs ( C , D ) show representative sections of <t>pErbB3</t> expression in erlotinib-treated AsPC-1 and AsPC-1+CAF xenografts. A high power (20 × ) view demonstrates positive membranous pattern, scored as intensity 2 on a 0–3 scale ( D ), the opposite ( C ) shows negative staining. The photographs ( E , F ) show representative sections of pErbB3 staining in placebo-treated AsPC-1 and AsPC-1+CAF xenografts.
Perbb3 Y1197, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/perbb3 y1197/product/Cell Signaling Technology Inc
Average 94 stars, based on 1 article reviews
perbb3 y1197 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

98
Cell Signaling Technology Inc perbb3 y1289 cell signaling technology
IHC analysis of xenograft tumours with and without CAF and effect of erlotinib treatment. The photographs ( A , B ) show low power (4 × ) representative sections of α -SMA staining of AsPC-1 and AsPC-1+CAF xenografts, respectively. The photographs ( C , D ) show representative sections of <t>pErbB3</t> expression in erlotinib-treated AsPC-1 and AsPC-1+CAF xenografts. A high power (20 × ) view demonstrates positive membranous pattern, scored as intensity 2 on a 0–3 scale ( D ), the opposite ( C ) shows negative staining. The photographs ( E , F ) show representative sections of pErbB3 staining in placebo-treated AsPC-1 and AsPC-1+CAF xenografts.
Perbb3 Y1289 Cell Signaling Technology, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/perbb3 y1289 cell signaling technology/product/Cell Signaling Technology Inc
Average 98 stars, based on 1 article reviews
perbb3 y1289 cell signaling technology - by Bioz Stars, 2026-03
98/100 stars
  Buy from Supplier

90
Cell Signaling Technology Inc pmapk 4377s antibody
Signal pathway changes in MMP-28 treated DRG cultures . A) Western blot analysis of pErbB-2, <t>pErbB3,</t> pPI3K (p55/p85) and phosphoMAPK in rat DRG co-cultures at 0, 1, 5, 10, 15, and 20 minutes following addition of fresh media with or without 10 nM MMP-28. Equal protein loading was determined by Ponceau-S staining of the membrane (not shown) and Coomassie staining of a parallel, equally loaded gel. B) Immunofluorescence of pErbB3 in DRG co-cultures 20 minutes after addition of fresh media containing 10 nM MMP-28 preincubated with 30 nM rabbit IgG, pAb180 or pAb183. Blue:DAPI, Red:pErbB3, Green:Acetylated C,D) Determination of proliferation in DRG co-cultures following MMP-28 treatment using PCNA. C) Relative fluorescence units were counted in 14 day myelinating cultures in control and treated samples. D) Percent of proliferating cells after 2 days in culture was determined by counting PCNA positive nuclei. N = 3, ± SD.
Pmapk 4377s Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pmapk 4377s antibody/product/Cell Signaling Technology Inc
Average 90 stars, based on 1 article reviews
pmapk 4377s antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
CH Instruments chi-square test
Signal pathway changes in MMP-28 treated DRG cultures . A) Western blot analysis of pErbB-2, <t>pErbB3,</t> pPI3K (p55/p85) and phosphoMAPK in rat DRG co-cultures at 0, 1, 5, 10, 15, and 20 minutes following addition of fresh media with or without 10 nM MMP-28. Equal protein loading was determined by Ponceau-S staining of the membrane (not shown) and Coomassie staining of a parallel, equally loaded gel. B) Immunofluorescence of pErbB3 in DRG co-cultures 20 minutes after addition of fresh media containing 10 nM MMP-28 preincubated with 30 nM rabbit IgG, pAb180 or pAb183. Blue:DAPI, Red:pErbB3, Green:Acetylated C,D) Determination of proliferation in DRG co-cultures following MMP-28 treatment using PCNA. C) Relative fluorescence units were counted in 14 day myelinating cultures in control and treated samples. D) Percent of proliferating cells after 2 days in culture was determined by counting PCNA positive nuclei. N = 3, ± SD.
Chi Square Test, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/chi-square test/product/CH Instruments
Average 90 stars, based on 1 article reviews
chi-square test - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

94
R&D Systems anti perbb3
Signal pathway changes in MMP-28 treated DRG cultures . A) Western blot analysis of pErbB-2, <t>pErbB3,</t> pPI3K (p55/p85) and phosphoMAPK in rat DRG co-cultures at 0, 1, 5, 10, 15, and 20 minutes following addition of fresh media with or without 10 nM MMP-28. Equal protein loading was determined by Ponceau-S staining of the membrane (not shown) and Coomassie staining of a parallel, equally loaded gel. B) Immunofluorescence of pErbB3 in DRG co-cultures 20 minutes after addition of fresh media containing 10 nM MMP-28 preincubated with 30 nM rabbit IgG, pAb180 or pAb183. Blue:DAPI, Red:pErbB3, Green:Acetylated C,D) Determination of proliferation in DRG co-cultures following MMP-28 treatment using PCNA. C) Relative fluorescence units were counted in 14 day myelinating cultures in control and treated samples. D) Percent of proliferating cells after 2 days in culture was determined by counting PCNA positive nuclei. N = 3, ± SD.
Anti Perbb3, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti perbb3/product/R&D Systems
Average 94 stars, based on 1 article reviews
anti perbb3 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

Image Search Results


IHC analysis of xenograft tumours with and without CAF and effect of erlotinib treatment. The photographs ( A , B ) show low power (4 × ) representative sections of α -SMA staining of AsPC-1 and AsPC-1+CAF xenografts, respectively. The photographs ( C , D ) show representative sections of pErbB3 expression in erlotinib-treated AsPC-1 and AsPC-1+CAF xenografts. A high power (20 × ) view demonstrates positive membranous pattern, scored as intensity 2 on a 0–3 scale ( D ), the opposite ( C ) shows negative staining. The photographs ( E , F ) show representative sections of pErbB3 staining in placebo-treated AsPC-1 and AsPC-1+CAF xenografts.

Journal: British Journal of Cancer

Article Title: Targeting ErbB3-mediated stromal–epithelial interactions in pancreatic ductal adenocarcinoma

doi: 10.1038/bjc.2011.263

Figure Lengend Snippet: IHC analysis of xenograft tumours with and without CAF and effect of erlotinib treatment. The photographs ( A , B ) show low power (4 × ) representative sections of α -SMA staining of AsPC-1 and AsPC-1+CAF xenografts, respectively. The photographs ( C , D ) show representative sections of pErbB3 expression in erlotinib-treated AsPC-1 and AsPC-1+CAF xenografts. A high power (20 × ) view demonstrates positive membranous pattern, scored as intensity 2 on a 0–3 scale ( D ), the opposite ( C ) shows negative staining. The photographs ( E , F ) show representative sections of pErbB3 staining in placebo-treated AsPC-1 and AsPC-1+CAF xenografts.

Article Snippet: Sections were then incubated overnight with primary monoclonal antibodies for pErbB3 and α -SMA (Santa Cruz Biotechnology).

Techniques: Staining, Expressing, Negative Staining

Signal pathway changes in MMP-28 treated DRG cultures . A) Western blot analysis of pErbB-2, pErbB3, pPI3K (p55/p85) and phosphoMAPK in rat DRG co-cultures at 0, 1, 5, 10, 15, and 20 minutes following addition of fresh media with or without 10 nM MMP-28. Equal protein loading was determined by Ponceau-S staining of the membrane (not shown) and Coomassie staining of a parallel, equally loaded gel. B) Immunofluorescence of pErbB3 in DRG co-cultures 20 minutes after addition of fresh media containing 10 nM MMP-28 preincubated with 30 nM rabbit IgG, pAb180 or pAb183. Blue:DAPI, Red:pErbB3, Green:Acetylated C,D) Determination of proliferation in DRG co-cultures following MMP-28 treatment using PCNA. C) Relative fluorescence units were counted in 14 day myelinating cultures in control and treated samples. D) Percent of proliferating cells after 2 days in culture was determined by counting PCNA positive nuclei. N = 3, ± SD.

Journal: BMC Neuroscience

Article Title: MMP-28 as a regulator of myelination

doi: 10.1186/1471-2202-9-83

Figure Lengend Snippet: Signal pathway changes in MMP-28 treated DRG cultures . A) Western blot analysis of pErbB-2, pErbB3, pPI3K (p55/p85) and phosphoMAPK in rat DRG co-cultures at 0, 1, 5, 10, 15, and 20 minutes following addition of fresh media with or without 10 nM MMP-28. Equal protein loading was determined by Ponceau-S staining of the membrane (not shown) and Coomassie staining of a parallel, equally loaded gel. B) Immunofluorescence of pErbB3 in DRG co-cultures 20 minutes after addition of fresh media containing 10 nM MMP-28 preincubated with 30 nM rabbit IgG, pAb180 or pAb183. Blue:DAPI, Red:pErbB3, Green:Acetylated C,D) Determination of proliferation in DRG co-cultures following MMP-28 treatment using PCNA. C) Relative fluorescence units were counted in 14 day myelinating cultures in control and treated samples. D) Percent of proliferating cells after 2 days in culture was determined by counting PCNA positive nuclei. N = 3, ± SD.

Article Snippet: Antibodies were obtained from Cell Signaling Technologies, catalogue numbers as follows: pErbB2 2249S, pErbB3 4784P, pMAPK 4377S, pPI3K 4228P, or LabVision: PCNA Ab-1, PC10.

Techniques: Western Blot, Staining, Immunofluorescence, Fluorescence